Calgary, Alberta--(Newsfile Corp. - January 16, 2026) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), the leading autologous stem…
Expanding adoption, evidence, and innovation to support earlier identification and intervention across care and researchBOSTON, Jan. 16, 2026 /PRNewswire/ --…
FRISCO, Texas and TEMPE, Ariz., Jan. 16, 2026 /PRNewswire/ -- AllyGPO® and BioCareSD®, a strategic partnership serving community-based specialty practices,…
PALI-2108 Abstracts Highlight Gut-Targeted PDE4B Inhibition and Translational Phase 1a Findings in Ulcerative Colitis Carlsbad, CA, Jan. 16, 2026 (GLOBE…
GUILDFORD, SURREY / ACCESS Newswire / January 16, 2026 / CelLBxHealth plc (AIM:CLBX), a leader in circulating tumour cell (CTC)…
Registration Link for Phio's Presentation on Thursday, January 22 at 1:45 PM ETKing of Prussia, Pennsylvania--(Newsfile Corp. - January 15,…
CID-103 is a potential best-in-class, anti-CD38 monoclonal antibody; binds to unique CD38 epitopeAMR is a leading cause of kidney transplant…
The Science, Clinical Promise, & Market OutlookMELBOURNE, Australia, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc”…
Celia Reyes will lead Metabolon's global people strategy as the company continues to scale in the evolving multiomics marketplaceMORRISVILLE, N.C.,…
Celia Reyes will lead Metabolon's global people strategy as the company continues to scale in the evolving multiomics marketplaceMORRISVILLE, N.C.,…